Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders.
The Added Value of Family Material in the Discovery of Multiple Sclerosis Genes.
Anti-CD20 monoclonal antibodies in multiple sclerosis.
Multiple Sclerosis and Obesity: Possible Roles of Adipokines.
Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis.
Quality of life in relapsing-remitting multiple sclerosis patients receiving CinnoVex compared with Avonex.
Schwann cell proliferation and differentiation that is induced by ferulic acid through MEK1/ERK1/2 signalling promotes peripheral nerve remyelination following crush injury in rats.
Neurorehabilitation: applied neuroplasticity.
Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.
INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY.
Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.
Pediatric multiple sclerosis: Cognition and mood.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.
Dynamic Response Genes in CD4+ T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis.
Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study.
Cognitive Impairment in Multiple Sclerosis.
Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study.
Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department.
Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.
Transplantation of Pro-Oligodendroblasts, Preconditioned by LPS-Stimulated Microglia, Promotes Recovery after Acute Contusive Spinal Cord Injury.
Fully-integrated framework for the segmentation and registration of the spinal cord white and gray matter.
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Pages
« first
‹ previous
…
779
780
781
782
783
784
785
786
787
…
next ›
last »